person · Reporting owner
Cantley Lewis Clayton Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC.AGIO · Entity 4499 | Director | December 06, 2017 | December 08, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGIOS PHARMACEUTICALS, INC.
Report date December 06, 2017 · Filed December 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 79,475 |
Ending reported balance
After 2017-12-07 transaction · row 9
5 source rows · reconciled sequenceRow 1 · 2017-12-06 · Sale · Disposed 543 · Balance 80,851 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2017-12-06 · Sale · Disposed 253 · Balance 80,598 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 5 · 2017-12-06 · Sale · Disposed 204 · Balance 80,394 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 7 · 2017-12-07 · Sale · Disposed 288 · Balance 80,106 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 9 · 2017-12-07 · Sale · Disposed 631 · Balance 79,475 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 80,892 |
Reported balance
After 2017-12-06 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2017-12-06 · Sale · Disposed 542 · Balance 80,892 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 80,638 |
Reported balance
After 2017-12-06 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2017-12-06 · Sale · Disposed 254 · Balance 80,638 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 80,434 |
Reported balance
After 2017-12-06 transaction · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · 2017-12-06 · Sale · Disposed 204 · Balance 80,434 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 80,146 |
Reported balance
After 2017-12-07 transaction · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · 2017-12-07 · Sale · Disposed 288 · Balance 80,146 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 79,515 |
Reported balance
After 2017-12-07 transaction · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · 2017-12-07 · Sale · Disposed 631 · Balance 79,515 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 20,803 |
Reported balance
Holding disclosure · report date 2017-12-06 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 20,803 F8: Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant. |
| Common stockSEC Table I · non-derivative | IndirectSee footnote | 20,803 |
Reported balance
Holding disclosure · report date 2017-12-06 · row 12
Holding and transaction disclosures are not merged.
1 source rowRow 12 · Balance 20,803 F9: Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $57.48 to $58.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Shares held by Vicki Lee Sato, who is the reporting person's spouse.
F4: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.58 to $59.21. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $59.62 to $60.55. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $58.99 to $59.95. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $60.00 to $60.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8: Shares held by grantor retained annuity trusts for the benefit of the reporting person and his two children, of which the reporting person is trustee and sole annuitant.
F9: Shares held by grantor retained annuity trusts for the benefit of the reporting person's spouse and their two children, of which the reporting person's spouse is trustee and sole annuitant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 18, 2017 Filed Apr 19, 2017 21:16 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $50.92 | $25,918.28 |
DisclosureSEC source: 0001209191-17-027509 · doc4.xml · nonDerivative · entry 5 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,715 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.10 to $51.84. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:16 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 1,527 | $55.27 | $84,397.29 |
DisclosureSEC source: 0001209191-17-027509 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 92,264 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:16 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 1,527 | $55.27 | $84,397.29 |
DisclosureSEC source: 0001209191-17-027509 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,224 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.49. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:16 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $55.13 | $28,061.17 |
DisclosureSEC source: 0001209191-17-027509 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 93,791 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.83 to $55.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 21:16 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $55.13 | $28,061.17 |
DisclosureSEC source: 0001209191-17-027509 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,751 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $54.83 to $55.50. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 23, 2017 Filed Mar 24, 2017 20:20 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $53.91 | $27,440.19 |
DisclosureSEC source: 0001209191-17-022761 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 94,300 F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.50 to $54.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| March 23, 2017 Filed Mar 24, 2017 20:20 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $53.91 | $27,440.19 |
DisclosureSEC source: 0001209191-17-022761 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,260 F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.50 to $54.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 20:20 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $52.31 | $26,625.79 |
DisclosureSEC source: 0001209191-17-022761 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 94,809 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.50 to $52.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 20:20 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 509 | $52.31 | $26,625.79 |
DisclosureSEC source: 0001209191-17-022761 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,769 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.50 to $52.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 20:03 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 625 | $48.97 | $30,606.25 |
DisclosureSEC source: 0001209191-16-147275 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 107,818 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.26 to $49.68. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 20:03 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 627 | $48.97 | $30,704.19 |
DisclosureSEC source: 0001209191-16-147275 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,778 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.26 to $49.68. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 26, 2016 Filed Oct 28, 2016 20:03 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 625 | $48.91 | $30,568.75 |
DisclosureSEC source: 0001209191-16-147275 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 108,443 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.49 to $49.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| October 26, 2016 Filed Oct 28, 2016 20:03 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 627 | $48.91 | $30,666.57 |
DisclosureSEC source: 0001209191-16-147275 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,405 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $48.49 to $49.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 28, 2016 Filed Sep 28, 2016 21:29 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 625 | $54.00 | $33,750.00 |
DisclosureSEC source: 0001209191-16-143040 · doc4.xml · nonDerivative · entry 4 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 109,068 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.71 to $54.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| September 28, 2016 Filed Sep 28, 2016 21:29 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 627 | $54.00 | $33,858.00 |
DisclosureSEC source: 0001209191-16-143040 · doc4.xml · nonDerivative · entry 3 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,032 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.71 to $54.26. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 27, 2016 Filed Sep 28, 2016 21:29 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 625 | $54.15 | $33,843.75 |
DisclosureSEC source: 0001209191-16-143040 · doc4.xml · nonDerivative · entry 2 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 109,693 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.63 to $54.56. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by Vicki Lee Sato, who is the reporting person's spouse. Read SEC document |
| September 27, 2016 Filed Sep 28, 2016 21:29 UTC | AGIOS PHARMACEUTICALS, INC. AGIO · Entity 4499 | SaleCommon stock | 627 | $54.15 | $33,952.05 |
DisclosureSEC source: 0001209191-16-143040 · doc4.xml · nonDerivative · entry 1 Cantley Lewis Clayton Jr. · CIK 0001581950 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,659 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.63 to $54.56. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.